{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreid4irevfhmkg2dyfnwcr6q3lc335vhrtguwe4ek27jbp7nimobo7m",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mixb5q2nlxe2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigmusjjt6cfyhc55e2wtir6gnblqsfrtpwovpv44xzb2qyngfhp4y"
    },
    "mimeType": "image/jpeg",
    "size": 284217
  },
  "path": "/news/2026-04-potential-therapeutic-alcohol-liver-disease.html",
  "publishedAt": "2026-04-07T21:40:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Scientists have identified a particular protein in the body that may influence the progression of alcohol-associated liver disease and drinking behavior. The protein aquaporin 9 (AQP9) helps liver cells absorb and excrete a byproduct of alcohol, which can be toxic to the body. The findings, published in Alcohol: Clinical and Experimental Research, point to AQP9 as a potential therapeutic target for the treatment of advanced liver disease and alcohol use disorder.",
  "title": "Researchers identify potential therapeutic target for alcohol-associated liver disease and alcohol use disorder"
}